Zobrazeno 1 - 10
of 88
pro vyhledávání: '"David S. Morgan"'
Autor:
Shaun D. McCullough, David S Morgan, Hannah J Smith, Annie M. Jarabek, Elizabeth M. Martin, David Diaz-Sanchez, Emma C. Bowers, Lisa A. Dailey, Emily R Aungst
Publikováno v:
Toxicol Sci
Inhaled chemical/material exposures are a ubiquitous part of daily life around the world. There is a need to evaluate potential adverse effects of both single and repeat exposures for thousands of chemicals and an exponentially larger number of expos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc9eff0e31c2163e8b0a8817ad82a3f5
https://doi.org/10.1093/toxsci/kfab128
https://doi.org/10.1093/toxsci/kfab128
Autor:
Mary Ann Thompson, Alexandra E. Kovach, Ashwini Yenamandra, Megan A. Desai, David S. Morgan, Nishitha Reddy, Tarsheen K. Sethi
Publikováno v:
Journal of Hematopathology. 14:269-275
Large B cell lymphomas (LBCL) are a heterogeneous group of diseases with variable presentations and prognoses. Rarely, LBCLs arise in the sinonasal tract and are distinct from extranodal NK/T-cell lymphoma which is more typical in this anatomic locat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6e86697563b24e0c81362784f3fb3df
https://doi.org/10.1007/s12308-021-00473-5
https://doi.org/10.1007/s12308-021-00473-5
Autor:
Philippe Armand, Kami J. Maddocks, Richard F. Ambinder, Weiyun Z. Ai, Rachel Rabinovitch, Cecil M. Benitez, Monika L. Metzger, Kirsten M Boughan, Alex F. Herrera, Celeste M. Bello, Matthew McKinney, Stuart Seropian, Patrick B. Johnston, Jennifer L. Burns, Richard T. Hoppe, Philip J. Bierman, Nadia Khan, Jane N. Winter, Bouthaina S. Dabaja, Karen C. Rosenspire, Carolyn Mulroney, Francisco J. Hernandez-Ilizaliturri, Jonathan McConathy, Leo I. Gordon, Joachim Yahalom, Jiayi Huang, Ranjana H. Advani, Randa Tao, Mark S. Kaminski, Vaishalee P. Kenkre, David S. Morgan, Ndiya Ogba, Ephraim P. Hochberg, Ryan C. Lynch
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:755-781
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN panel meets at least annually to review comments from reviewers within their institutions, exam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::718b42dfbada35fd35cf285243427dbc
https://doi.org/10.6004/jnccn.2020.0026
https://doi.org/10.6004/jnccn.2020.0026
Autor:
Hannah Harmsen, Pauleatha Diggs, Matthew T. Villaume, Vivek Patel, Mary Ann Thompson, Dilan A Patel, Christine R Lopez, David S. Morgan
Publikováno v:
World Journal of Oncology
Primary dural marginal zone lymphomas (MZLs) are exceptionally rare, with fewer than 100 cases reported to date. While the association between hepatitis C virus (HCV) infection and lymphoma is well established, it is unclear if this association exten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbe6acc1b2660a76de35b8434fdd2ad5
https://doi.org/10.14740/wjon1285
https://doi.org/10.14740/wjon1285
Autor:
Erin Butler, Aron Flagg, Filip Janku, Kelly Walkovich, Paul C. Hendrie, Gaurav Goyal, Don W. Coulter, Ling Zhang, Eli L. Diamond, Meghan A. Higman, Eric D. Jacobsen, Aaron M. Goodman, Anne C Raldow, Susan Darlow, Michael D. Hogarty, Ronald S. Go, Srinivas K. Tantravahi, Reem Karmali, Patrick K Campbell, Robert A. Baiocchi, Mary Anne Bergman, Alexandra Stefanovic, Ilia Buhtoiarov, David S. Morgan, Dita Gratzinger
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(11)
Histiocytic neoplasms are rare hematologic disorders accounting for less than 1% of cancers of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders can be highly variable, leading to challenges for diagnosis and opt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::878b75e48bfcd24034df4eeabba51ec3
https://pubmed.ncbi.nlm.nih.gov/34781268
https://pubmed.ncbi.nlm.nih.gov/34781268
Autor:
Evie Carchman, Julian Sanchez, Gita Suneja, Kevin L. Ard, Michelle A. Rudek, Mary A. Dwyer, Oxana V. Crysler, Neel K. Gupta, Allison Hall, David S. Morgan, Chelsea Gustafson, Manoj P. Menon, Lee Ratner, Benjamin Tomlinson, Jeff Taylor, Ann H. Klopp, Nitya Nathwani, Adam L. Cohen, Sai Yendamuri, Stacey A. Rizza, Deborah A. Freedman-Cass, Kimberly L. Johung, Richard F. Ambinder, Ann S. LaCasce, Chia Ching J. Wang, Robert A. Baiocchi, Ariela Noy, Erin Reid, Stefan K. Barta, Chi Lin, Amitkumar Mehta
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:171-189
As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin’s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still eleva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1a45ace1aae22a99cd22149c1bc8506
https://doi.org/10.6004/jnccn.2019.0008
https://doi.org/10.6004/jnccn.2019.0008
Autor:
Elad Sharon, David S. Morgan, Neil Palmisiano, Catherine Diefenbach, Reem Karmali, Stephen M. Ansell, Jakub Svoboda, Brad S. Kahl, Stefan K. Barta, Michael J. Robertson, Kevin A. David, Richard F. Ambinder, Ranjana H. Advani, Jonathon B. Cohen, Fangxin Hong, Timothy S. Fenske, Howard Streicher
Publikováno v:
Lancet Haematol
Summary Background Recognising that the immune suppressive microenvironment promotes tumour growth in Hodgkin lymphoma, we hypothesised that activating immunity might augment the activity of targeted chemotherapy. We evaluated the safety and activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1337124261649e9dfc1e4bd74a0f4c96
https://europepmc.org/articles/PMC7737486/
https://europepmc.org/articles/PMC7737486/
Autor:
Robert T. Chen, Andres Forero, Kami J. Maddocks, Philippe Armand, Ndiya Ogba, David S. Morgan, Francisco J. Hernandez-Ilizaliturri, Jane N. Winter, Joachim Yahalom, Carolyn Mulroney, Bouthaina S. Dabaja, Patrick B. Johnston, Joseph O. Moore, Jiayi Huang, Weiyun Z. Ai, Robert M. Dean, Rachel Rabinovitch, Craig H. Moskowitz, Jennifer L. Burns, Celeste M. Bello, Randa Tao, Cecil M. Benitez, Philip J. Bierman, Mark S. Kaminski, Vaishalee P. Kenkre, Leo I. Gordon, David G. Maloney, Monika L. Metzger, Nadia Khan, Stuart Seropian, Richard T. Hoppe, Ephraim P. Hochberg, Richard F. Ambinder, Ranjana H. Advani, Patricia Aoun
Publikováno v:
Journal of the National Comprehensive Cancer Network. 16:245-254
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Memb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cab65306320d7afb2aa4ac6a4e5f4312
https://doi.org/10.6004/jnccn.2018.0013
https://doi.org/10.6004/jnccn.2018.0013
Autor:
Peter Mauch, Rachel Rabinovitch, Ephraim P. Hochberg, David G. Maloney, Karl Bernat, Matthew M. Poppe, Stuart Seropian, Cecil M. Benitez, Richard T. Hoppe, Robert T. Chen, Weiyun Z. Ai, Andres Forero, Nadia Khan, Patricia Aoun, Bouthaina S. Dabaja, Monika L. Metzger, Patrick B. Johnston, David S. Morgan, Joseph O. Moore, Jane N. Winter, Mitchell R. Smith, Carolyn Mulroney, Ndiya Ogba, Joachim Yahalom, Francisco J. Hernandez-Ilizaliturri, Hema Sundar, Jiayi Huang, Kristie A. Blum, Ranjana H. Advani, Leo I. Gordon, Celeste M. Bello, Mark S. Kaminski, Vaishalee P. Kenkre, Philip J. Bierman, Craig H. Moskowitz, Jennifer L. Burns, Richard F. Ambinder
Publikováno v:
Journal of the National Comprehensive Cancer Network. 15:608-638
This portion of the NCCN Guidelines for Hodgkin lymphoma (HL) focuses on the management of classical HL. Current management of classical HL involves initial treatment with chemotherapy or combined modality therapy followed by restaging with PET/CT to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eec590990b5885258d133f4cb9dea7e
https://doi.org/10.6004/jnccn.2017.0064
https://doi.org/10.6004/jnccn.2017.0064
Autor:
Tarsheen K, Sethi, Alexandra E, Kovach, Natalie S, Grover, Li-Ching, Huang, Laura A, Lee, Samuel M, Rubinstein, Yang, Wang, David S, Morgan, John P, Greer, Steven I, Park, Mary, Ann Thompson-Arildsen, Ashwini, Yenamandra, Cindy L, Vnencak-Jones, Nishitha M, Reddy
Publikováno v:
Leuk Lymphoma
Primary central nervous system lymphoma (PCNSL) patients have a poorer prognosis than systemic lymphoma. Gain-of-function MYD88 c.794T>C (p. L265P) mutation and programmed cell death-1 (PD-1) pathway alterations are potential targetable pathways. Our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7cd7595341ec4e24cbd35412aabd1fce
https://pubmed.ncbi.nlm.nih.gov/31184237
https://pubmed.ncbi.nlm.nih.gov/31184237